Knight Therapeutics is a Canadian specialty pharmaceutical company listed on the Toronto Stock Exchange. The company focuses on acquiring, licensing, and selling innovative prescription and over-the-counter pharmaceutical products in Canada and select international markets, while also conducting late-stage clinical development on low-risk, low-expense product opportunities. Knight's products are all sourced through partnerships.